SEC Form 4 · accession 0001179110-16-021323
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sheela Mohan-Peterson
Officer — Chief Legal Officer
Period of report
Mar 4, 2016
Accepted (ET)
Mar 8, 2016 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $2.02 | Mar 4, 2016 | A | 60,000 | A | Mar 4, 2016 | Mar 4, 2026 | Common Stock | 60,000 | 150,250 | D |
| Restricted Stock UnitsF2,F3 | — | Mar 4, 2016 | A | 100,000 | A | Mar 4, 2019 | Mar 4, 2019 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F125% vested as of the Grant Date, with 1/36th of the remaining 75% of the shares to vest monthly thereafter.
- F2Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F3100% of the restricted stock units are scheduled to vest on March 4, 2019, assuming continued employment through the applicable vesting date.